156 related articles for article (PubMed ID: 3393597)
1. Platelet 3H-imipramine binding and response to minaprine in patients with major depression.
Maj M; Mastronardi P; Palomba U; Romano M; Ventra C; Kemali D
Pharmacopsychiatry; 1988 Mar; 21(2):101-3. PubMed ID: 3393597
[TBL] [Abstract][Full Text] [Related]
2. Minaprine and dose response in depression. An investigation of two fixed doses of minaprine compared with imipramine.
Montgomery SA; Baldwin DS; Priest RG; Steinert J; Patel A; Herrington RN; Livingston HM
Pharmacopsychiatry; 1991 Sep; 24(5):168-74. PubMed ID: 1775522
[TBL] [Abstract][Full Text] [Related]
3. Double-blind, placebo-controlled, fixed dose trial of minaprine in patients with major depression.
Amsterdam JD; Dunner DL; Fabre LF; Kiev A; Rush AJ; Goodman LI
Pharmacopsychiatry; 1989 Jul; 22(4):137-43. PubMed ID: 2668978
[TBL] [Abstract][Full Text] [Related]
4. Minaprine and imipramine in the treatment of major depressive disorders. A comparative double-blind study.
Bohacek N; Ravic M; Bizière K
Drugs Exp Clin Res; 1987; 13(7):435-42. PubMed ID: 3308390
[TBL] [Abstract][Full Text] [Related]
5. Platelet 3H imipramine binding: a possible predictor of response to antidepressant treatment.
Hrdina PD; Lapierre YD; Horn ER; Bakish D
Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(5-6):619-23. PubMed ID: 3003804
[TBL] [Abstract][Full Text] [Related]
6. 3H-imipramine platelet binding sites in unipolar depression.
Baron M; Barkai A; Gruen R; Kowalik S; Quitkin F
Biol Psychiatry; 1983 Dec; 18(12):1403-9. PubMed ID: 6661469
[TBL] [Abstract][Full Text] [Related]
7. [3H-Imipramine binding to human platelets. A peripheral index in depressive syndromes (author's transl)].
Zarifian E; Sechter D; Bouchami F; Cuche H; Olie JP; Susini JR; Loo H; Briley M; Raisman R; Langer SZ
Nouv Presse Med; 1982 Apr; 11(18):1385-7. PubMed ID: 7079155
[TBL] [Abstract][Full Text] [Related]
8. [Sensitivity of the retrograde uptake of H3-serotonin to imipramine and trazodone in patients with endogenous depression treated with antidepressive drugs].
Katasonov AB; Beliaev BS; Zlobina GP; Faktor MI; Brusov OS
Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(2):125-8. PubMed ID: 2728713
[TBL] [Abstract][Full Text] [Related]
9. Lithium addition in antidepressant-resistant depression: effects on platelet 5-HT, plasma 5-HT and plasma 5-HIAA concentration.
Birkenhäger TK; van den Broek WW; Fekkes D; Mulder PG; Moleman P; Bruijn JA
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1084-8. PubMed ID: 17467132
[TBL] [Abstract][Full Text] [Related]
10. Comparative study of platelet 3H-paroxetine and 3H-imipramine binding in panic disorder patients and healthy controls.
Faludi G; Tekes K; Tóthfalusi L
J Psychiatry Neurosci; 1994 Mar; 19(2):109-13. PubMed ID: 8204562
[TBL] [Abstract][Full Text] [Related]
11. Platelet 3H-imipramine binding: a state-dependent marker in depression.
Suranyi-Cadotte B; Quirion R; McQuade P; Nair NP; Schwartz G; Mosticyan S; Wood PL
Prog Neuropsychopharmacol Biol Psychiatry; 1984; 8(4-6):737-41. PubMed ID: 6531445
[TBL] [Abstract][Full Text] [Related]
12. Imipramine binding as a predictor of fluoxetine response in depressed patients.
Castrogiovanni P; Di Muro A; Marazziti D
Neuropsychobiology; 1995; 31(2):64-7. PubMed ID: 7760987
[TBL] [Abstract][Full Text] [Related]
13. Platelet [3H]imipramine and [3H]paroxetine binding in depressed patients.
Rosel P; Menchón JM; Vallejo J; Arranz B; Navarro MA; Lirón F; Alvarez P
J Affect Disord; 1997 Jun; 44(1):79-85. PubMed ID: 9186805
[TBL] [Abstract][Full Text] [Related]
14. Multicentric double-blind study comparing efficacy and safety of minaprine and imipramine in dysthymic disorders.
Salzmann E; Robin JL
Neuropsychobiology; 1995; 31(2):68-75. PubMed ID: 7760988
[TBL] [Abstract][Full Text] [Related]
15. Alteration of platelet [3H]imipramine binding in mildly depressed patients correlates with disease severity.
Tanimoto K; Maeda K; Terada T
Biol Psychiatry; 1985 Mar; 20(3):340-3. PubMed ID: 2983789
[No Abstract] [Full Text] [Related]
16. Lack of association between platelet tritiated imipramine binding and clinical status of depressed patients on chronic antidepressant treatment.
Gronier B; Azorin JM; Dassa D; Jeanningros R
Eur Neuropsychopharmacol; 1994 Mar; 4(1):7-14. PubMed ID: 8204999
[TBL] [Abstract][Full Text] [Related]
17. Reduced Bmax of [3H]-imipramine binding to platelets of depressed patients free of previous medication with 5HT uptake inhibitors.
Poirier MF; Benkelfat C; Loo H; Sechter D; Zarifian E; Galzin AM; Langer SZ
Psychopharmacology (Berl); 1986; 89(4):456-61. PubMed ID: 3092276
[TBL] [Abstract][Full Text] [Related]
18. A double-blind study of minaprine versus amitriptyline in major depression.
Del Zompo M; Bernardi F; Burrai C; Bocchetta A
Neuropsychobiology; 1990-1991; 24(2):79-83. PubMed ID: 2134115
[TBL] [Abstract][Full Text] [Related]
19. Platelet [3H]imipramine binding in affective disorders: trait versus state characteristics.
Baron M; Barkai A; Gruen R; Peselow E; Fieve RR; Quitkin F
Am J Psychiatry; 1986 Jun; 143(6):711-7. PubMed ID: 3717391
[TBL] [Abstract][Full Text] [Related]
20. Circadian variation in platelet imipramine binding during the day in healthy subjects.
Ellis PM; Beeston R; Cooke RR; Mellsop G
Pharmacopsychiatry; 1991 May; 24(3):76-80. PubMed ID: 1891484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
